In this podcast, Gregory Sayuk, MD, MPH, speaks about the different types of treatment options available for patients with irritable bowel syndrome (IBS) and irritable bowel syndrome with diarrhea (IBS-D),...
In a new study, researchers sought to clarify how the gut microbe may influence chronic gastrointestinal disease. The coauthors Michael C. Hoaglin, MD, and Melissa Agnello, PhD, answered our questions about...
Darren Brenner, MD, from Northwestern Medicine, discusses the current management of IBS, findings from the RELIEF phase 4 clinical trial of IBS-D, why targeting underlying pathogenic mechanisms of IBS...
In this commentary, Brian E. Lacy, MD, PhD, from the Mayo Clinic, describes an holistic approach for managing IBS, how gastroenterologists can approach discussing psychological therapeutic options with...
Joshua Z. Goldenberg, ND, answered our questions about his team’s study aimed to assess the efficacy and safety of biofeedback-based interventions for treating irritable bowel syndrome among adults and...
Maitreyi Raman, MD, MSc, answers our questions about how the low FODMAP diet affects irritable bowel syndrome symptoms, concerns about prescribing the low FODMAP diet, and factors that need to be considered...
Michael Camilleri, MD, from the Mayo Clinic, answers our questions about his research on fecal bile acids and fecal fat as potential biomarkers for irritable bowel syndrome, the importance of individualized...
Magnus Simrén, MD, PhD, answers our questions about his research that assessed whether human milk oligosaccharides could improve bowel symptoms in patients with irritable bowel syndrome.
Sarah Ballou, PhD, answers our questions about her research on the effects of IBS on daily function between disease subtypes, as well as about current IBS management challenges and more.
Rachel Adams, MS, RD, answers our questions on her research about how individuals with irritable bowel syndrome relate their symptoms to diet, as well as the role of diet in the overall management of the...
